Earnings History Data for Marker Therapeutics, Inc. (MRKR) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Marker Therapeutics, Inc.

Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company specializing in the development of innovative peptide and nucleic acid-based immunotherapeutic vaccines for the treatment and eradication of cancer, including metastatic cancer. The company's product pipeline consists of MultiTAA T Cell Therapy, TPIV200 and TPIV100/110 which are in clinical stage. Marker Therapeutics Inc., formerly known as TapImmune Inc., is based in FL, United States.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
22-03-2023	??	Before the open (Mar 22)	MRKR	Marker Therapeutics, Inc.	18.79	N/A	0.00	-1.20	Marker Therapeutics GAAP EPS of -$3.58 beats by $0.02, revenue of $9.01M beats by $0.01M [3/22/2023 8:45 AM]	0.9398	-0.26 (-21.68%)	1.20	0.0 (0.00%)	0.88 - 5.20	343,386	60,000	1,584
Marker Therapeutics GAAP EPS of -$3.58 beats by $0.02, revenue of $9.01M beats by $0.01M [3/22/2023 8:45 AM]
11-08-2022	AH	After the close (Aug 11)	MRKR	MARKER THERAPEUTICS	43.00	-0.11	-0.13	0.00	Marker Therapeutics GAAP EPS of -$0.11 misses by $0.01, revenue of $0.79M misses by $1.71M [8/11/2022 5:03 PM]	0.3963	-0.05 (-11.64%)	0.45	0.0 (0.33%)	0.25 - 2.05	929,285	9,690,000	15,284
Marker Therapeutics GAAP EPS of -$0.11 misses by $0.01, revenue of $0.79M misses by $1.71M [8/11/2022 5:03 PM] Marker Therapeutics Reports Q2 2022 Operating and Financial Results [Aug-11-22 04:22PM]
13-05-2022	PM	Before the open (May 13)	MRKR	MARKER THERAPEUTICS	26.00	-0.12	-0.13	0.00	Marker Therapeutics GAAP EPS of -$0.12 beats by $0.01, revenue of $964.32M [5/13/2022 7:48 AM]	0.3270	0.01 (4.14%)	0.31	0.0 (-1.27%)	0.28 - 3.65	478,383	260,000	447
Marker Therapeutics GAAP EPS of -$0.12 beats by $0.01, revenue of $964.32M [5/13/2022 7:48 AM] Marker Therapeutics Reports Q1 2022 Operating and Financial Results [May-13-22 07:00AM]
17-03-2022	AH		MRKR	MARKER THERAPEUTICS	33.00	-0.12	-0.12	0.00	Marker Therapeutics GAAP EPS of -$0.55 beats by $0.02, revenue of $1.24M [3/17/2022 6:05 PM]	0.4348	0.0 (0.79%)	0.4411	0.01 (2.25%)	0.35 - 3.65	458,357	740,077	11,001
Marker Therapeutics GAAP EPS of -$0.55 beats by $0.02, revenue of $1.24M [3/17/2022 6:05 PM] Marker Therapeutics Reports Fiscal Year 2021 Operating and Financial Results [Mar-17-22 05:45PM]
10-11-2021	AH		MRKR	MARKER THERAPEUTICS	125.00	-0.12	-0.13	0.00	Marker Therapeutics EPS misses by $0.02 [11/10/2021 4:38 PM]	1.42	-0.05 (-3.40%)	1.47	0.0 (0.00%)	1.38 - 3.77	397,450	250,000	1,001
Marker Therapeutics EPS misses by $0.02 [11/10/2021 4:38 PM] Marker Therapeutics Reports Third Quarter 2021 Operating and Financial Results [Nov-10-21 04:05PM]
10-08-2021	AH	4:05 PM ET (Aug 10)	MRKR	Marker Therapeutics, Inc.	173.50	-0.13	-0.12	-0.14	Marker Therapeutics EPS misses by $0.01 [8/10/2021 5:14 PM]	1.98	-0.03 (-1.74%)	2.00	-0.01 (-0.50%)	1.32 - 3.77	682,787	300,000	5,425
Marker Therapeutics EPS misses by $0.01 [8/10/2021 5:14 PM] Is Marker Therapeutics, Inc.'s (NASDAQ:MRKR) Shareholder Ownership Skewed Towards Insiders? [Aug-09-21 06:57AM] Marker Therapeutics Reports Second Quarter 2021 Operating and Financial Results [Aug-10-21 04:01PM]
12-05-2021	AH	4:10 PM ET (May 12)	MRKR	Marker Therapeutics, Inc.	195.08	-0.16	-0.16	-0.14	Marker Therapeutics EPS misses by $0.02 [5/12/2021 4:22 PM]	2.11	-0.05 (-2.55%)	2.22	0.06 (2.78%)	1.32 - 3.77	3,144,505	1,680,000	7,477
Marker Therapeutics EPS misses by $0.02 [5/12/2021 4:22 PM] Marker Therapeutics, Inc. to Host Earnings Call [May-12-21 02:45PM] Marker Therapeutics Reports First Quarter 2021 Operating and Financial Results [May-12-21 04:05PM]
09-03-2021	AH	4:00 PM ET (Mar 9)	MRKR	Marker Therapeutics, Inc.	109.00	-0.18	-0.16	0.00	Marker Therapeutics EPS misses by $0.02, misses on revenue [3/9/2021 4:27 PM]	2.49	-0.02 (-0.80%)	2.55	0.04 (1.59%)	1.32 - 3.77	182,981	335,821	12,051
Marker Therapeutics EPS misses by $0.02, misses on revenue [3/9/2021 4:27 PM] Marker Therapeutics Reports Fiscal Year 2020 Operating and Financial Results [Mar-09-21 04:12PM]
09-11-2020	AH	4:00 PM ET (Nov 9)	MRKR	Marker Therapeutics, Inc.	66.20	-0.16	-0.15	-0.12	Marker Therapeutics EPS misses by $0.02 [11/9/2020 4:29 PM]	1.48	0.0 (-0.34%)	1.50	0.01 (0.67%)	1.32 - 4.08	176,128	173,772	1,618